Ginkgo Bioworks Holdings (DNA) Cash from Financing Activities: 2020-2025
Historic Cash from Financing Activities for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $9.9 million.
- Ginkgo Bioworks Holdings' Cash from Financing Activities rose 2237.20% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 534.96%. This contributed to the annual value of -$1.7 million for FY2024, which is 45.93% up from last year.
- Per Ginkgo Bioworks Holdings' latest filing, its Cash from Financing Activities stood at $9.9 million for Q3 2025, which was up 10,240.82% from -$98,000 recorded in Q2 2025.
- Over the past 5 years, Ginkgo Bioworks Holdings' Cash from Financing Activities peaked at $1.5 billion during Q3 2021, and registered a low of -$11.0 million during Q4 2021.
- For the 3-year period, Ginkgo Bioworks Holdings' Cash from Financing Activities averaged around $425,273, with its median value being -$315,000 (2023).
- Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 5,837.10% in 2021, then surged by 2,237.20% in 2025.
- Ginkgo Bioworks Holdings' Cash from Financing Activities (Quarterly) stood at -$11.0 million in 2021, then soared by 985.29% to $97.8 million in 2022, then slumped by 100.65% to -$632,000 in 2023, then surged by 67.88% to -$203,000 in 2024, then soared by 2,237.20% to $9.9 million in 2025.
- Its Cash from Financing Activities stands at $9.9 million for Q3 2025, versus -$98,000 for Q2 2025 and -$207,000 for Q1 2025.